Perceptive Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-100,000
Closed -$2.33M – 206
2016
Q2
$2.33M Buy
+100,000
New +$3.23M 0.16% 81

Other funds holding IONS

Perceptive Advisors's IONS Position: Q3 2026 in Review

Perceptive Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 566,000 shares — an estimated $44.9M sold.

Perceptive Advisors first reported a position in IONS in Q3 2013 and held it in 3 quarters. The position peaked at $44.9M in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Perceptive Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Perceptive Advisors sold 566,000 Ionis Pharmaceuticals shares in Q3 2026, an estimated $44.9M.
  • Perceptive Advisors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Perceptive Advisors's Ionis Pharmaceuticals position peaked at $44.9M in Q2 2026.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.